The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Prevalence of Adverse Drug Events in Ambulatory Care: A Systematic Review
Open accessAbstract
Objective: Most medications are prescribed, dispensed, and administered in ambulatory care settings, yet little information exists on the adverse effects of drugs in this setting. This review was conducted to estimate the prevalence of adverse drug events (ADEs) and the proportion of preventable ADEs in ambulatory care settings; compare data for different age groups including children, adults, and elderly patients; and review drug classes most commonly associated with ADEs. Data Sources: Four electronic databases–PubMed (1966-March 2011), International Pharmaceutical Abstracts (1970-March 2011), EMBASE (1980-March 2011), and the Cochrane Database of Systematic Reviews (1993-March 2011)—were systematically searched for published data. Bibliographies of retrieved articles were searched individually for additional relevant studies. Study Selection: A standardized definition of an ADE was used to select studies in populations living in the community, with medical visits to primary care facilities, nonspecialty ambulatory care facilities, and/or admissions to a hospital for medication-related adverse events. Data Extraction: Data were extracted using a standardized table. Forty-three studies met our inclusion criteria. Data Synthesis: The median ADE prevalence rate for retrospective studies was 3.3% (interquartile range [IQR] 2.3-7.1%) vs 9.65% (IQR 3.3-17.35%) for prospective studies. Median preventable ADE rates in ambulatory care–based studies were 16.5%, and 52.9% for hospital-based studies. Median prevalence rates by age group ranged from 2.45% for children to 5.27% for adults, 16.1% for elderly patients, and 3.45% for studies including all ages. Conclusions: Despite a recent increase in publications on ADEs in the ambulatory care setting, most studies remain hospital based. Notable differences in prevalence rates by age groups and by responsible drug categories provide guidance on how to direct attention toward effective targets for improvement of medication safety in ambulatory care settings.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reason, J. (1990) · doi:10.1017/cbo9781139062367 · Cited by 5,108
Incidence of Adverse Drug Events and Potential Adverse Drug Events: Implications for Prevention
Bates, D. W. (1995) · JAMA · doi:10.1001/jama.1995.03530010043033 · Cited by 2,127
Cited by
Epidemiology of Adverse Drug Reactions in Europe: A Review of Recent Observational Studies
Bouvy, J. C., De Bruin, M. L., & Koopmanschap, M. A. (2015) · Drug Safety · doi:10.1007/s40264-015-0281-0 · Cited by 466
Tommelein, E., Mehuys, E., Petrovic, M., Somers, A., Colin, P., & Boussery, K. (2015) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-015-1954-4 · Cited by 292
Assiri, G. A., Shebl, N. A., Mahmoud, M. A., Aloudah, N., Grant, E., Aljadhey, H., & Sheikh, A. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-019101 · Cited by 284
Tinetti, M. E., McAvay, G., Trentalange, M., Cohen, A. B., & Allore, H. G. (2015) · BMJ · doi:10.1136/bmj.h4984 · Cited by 58
Abbas, A., Al-Shaibi, S., Sankaralingam, S., Awaisu, A., Kattezhathu, V. S., Wongwiwatthananukit, S., & Owusu, Y. B. (2022) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-021-01346-8 · Cited by 29
Hughes, J. E., Bennett, K. E., & Cahir, C. (2024) · Clinical Drug Investigation · doi:10.1007/s40261-024-01369-9 · Cited by 13
Metadata
- Authors
- Taché, S. V., Sönnichsen, A., & Ashcroft, D. M.
- Venue
- Annals of Pharmacotherapy
- Publisher
- SAGE Publications
- Published
- 2011-06-21
- Volume
- 45
- Issue
- 7-8
- Pages
- 977-989
- ISSN
- 0012-6578 (ISSN-L)
- 1060-0280
- 1542-6270
- OpenAlex
- W2104973603
- Cited by
- 244
- References
- 2
- FWCI
- 1.36
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.